Skip to main content

Table 1 Characteristics of dyslipidemia patients with hypertension in the DYSIS-China database

From: Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy

Index With hypertension
(n = 17,096)
Age (years)
 Mean (SD) 66.6 (10.4)
 ≥ 65 years 9769 (57.1%)
Gender
 Female 8226 (48.1%)
 BMI [Mean (SD)] (kg/m2) 25.0 (3.3)
 BMI ≥ 28 kg/m2 2658 (15.6%)
 Course of hypertension [Mean (SD)] (year) 10.7 (9.7)
Smoking
 Current smoker 2105 (12.3%)
 Previous smoker 3099 (18.1%)
 Non-smoker 11,892 (69.6%)
Alcohol consumption
 Yes 1572 (9.2%)
 No 13,795 (80.7%)
 Gave up 1729 (10.1%)
 Sedentary lifestyle 3595 (21.0%)
 Family history of cardiovascular disease 1744 (10.2%)
 Systolic pressure [Mean (SD)] (mmHg) 135.5 (15.8)
 Diastolic pressure [Mean (SD)] (mmHg) 80.1 (10.2)
 TC [Mean (SD)] (mmol/L) 4.5 (1.2)
 LDL-C [Mean (SD)] (mmol/L) 2.6 (1.0)
 HDL-C [Mean (SD)] (mmol/L) 1.3 (0.4)
 TG [Mean (SD)] (mmol/L) 1.9 (1.4)
 Non HDL-C [Mean (SD)] (mmol/L) 3.3 (1.1)
 Uric acid [Mean (SD)] (μmol/L) 335.4 (99.7)
 Creatinine [Mean (SD)] (μmol/L) 81.7 (35.8)
 CKD 1502 (8.8%)
 Diabetes 6289 (36.8%)
 CHD 6958 (40.7%)
 CVD 3363 (19.7%)
 Heart failure 767 (4.5%)
 Peripheral vascular disease 215 (1.3%)
Number of comorbiditiesa
 0 4597 (26.9%)
 1 7522 (44.0%)
 2 3659 (21.4%)
 > 3 1318 (7.7%)
 Antihypertension treatment 15,373 (89.9%)
 Monotherapy 8641 (50.5%)
 Combination therapy 6732 (39.4%)
 Antiplatelet therapy 11,989 (70.1%)
 Statin treatment 15,363 (89.9%)
Tier of Hospitals
 Tier 1 4117 (24.1%)
 Tier 2 4433 (25.9%)
 Tier 3 8546 (50.0%)
Department
 General medicine 4476 (26.2%)
 Geriatric 2034 (11.9%)
 Endocrine 2246 (13.1%)
 Other 1199 (7.0%)
 Neurology 2062 (12.1%)
 Cardiology 5079 (29.7%)
  1. a The comorbidities included CKD, chronic kidney disease; CHD, chronic heart disease; CVD, cerebrovascular disease, diabetes and heart failure as well as peripheral vascular disease
  2. SD, standard deviation; TC: total cholesterol; TG, triglyceride; CKD, chronic kidney disease; CHD, coronary heart disease; CVD, cerebrovascular disease; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein-cholesterol; BMI, body mass index. Other: departments except general medicine, geriatric, endocrinology, neurology and cardiology